Natalia Blanco

Natalia Blanco

Company: Morphic Therapeutics

Job title: Principle Scientist


Inhibition of Integrin αvβ8 in Combination with Low Dose Radiation Induces Antitumor Effect in Advanced Immune Checkpoint Blockade Refractory Tumor Model 11:00 am

Integrin αvβ8 mediates cell-type-specific activation of TGFβ1/3 to regulate the immune responses TGFβ immunosuppressive activity is implicated in radiotherapy resistance Inhibition of αvβ8 in combination with RIT eradicated an advanced tumor, unresponsive to the respective monotherapies or conventional RITRead more

day: Track A - Day 1 AM

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.